Cefpodoxime — Membership Pricing

Other medications in Infections

• Cefprozil
• Ceftibuten
• Cefuroxime
• Cephalexin
• Chloramphenicol
• Cidofovir
• Clarithromycin
• Colistin

About Cefpodoxime

Cefpodoxime is a widely prescribed antibiotic used to combat various bacterial infections. As an effective treatment, understanding its role and managing its cost is essential. With TheDrugClub, you can unlock significant savings on your cefpodoxime prescriptions, making vital medications more affordable and accessible for you and your family.

What is Cefpodoxime and What Does It Treat?

Cefpodoxime is a broad-spectrum cephalosporin antibiotic, commonly prescribed for a range of bacterial infections affecting different parts of the body. This includes upper and lower respiratory tract infections such as bronchitis, pneumonia, and sinusitis, as well as ear infections (otitis media), skin and soft tissue infections, and urinary tract infections (UTIs). It's important to remember that cefpodoxime, like all antibiotics, is only effective against bacterial infections and will not work for viral illnesses like the common cold or flu. Your doctor will determine if cefpodoxime is the right treatment for your specific condition.

How Cefpodoxime Works to Fight Infection

Cefpodoxime belongs to the third-generation cephalosporin class of antibiotics. Its mechanism of action involves interfering with the synthesis of bacterial cell walls. Bacteria rely on strong cell walls to maintain their structure and survive. Cefpodoxime works by binding to specific proteins (penicillin-binding proteins or PBPs) located in the bacterial cell wall. This binding prevents the bacteria from building and repairing their cell walls, leading to weakened cell walls, bacterial lysis (bursting), and ultimately, the death of the bacteria. This targeted action helps eradicate the

The information above is for educational purposes only and does not constitute medical advice. Consult your healthcare provider before making medication decisions.

What Cefpodoxime is approved for (FDA label)

Cefpodoxime proxetil is indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the conditions listed below. Recommended dosages, durations of therapy, and applicable patient populations vary among these infections. Please see DOSAGE AND ADMINISTRATION for specific recommendations. Acute otitis media caused by Streptococcus pneumoniae (excluding penicillin-resistant strains), Streptococcus pyogenes , Haemophilus influenzae (including beta-lactamase-producing strains), or Moraxella (Branhamella) catarrhalis (including beta-lactamase-producing strains). Pharyngitis and/or tonsillitis caused by Streptococcus pyogenes . NOTE: Only penicillin by the intramuscular route of administration has been shown to be effective in the prophylaxis of rheumatic fever. Cefpodoxime proxetil is generally effective in the eradication of streptococci from the oropharynx.

Source: Read the full FDA label on DailyMed. Label effective date: August 25, 2026.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Adverse reactions for Cefpodoxime (FDA label)

Clinical Trials: Film-coated Tablets (Multiple dose): In clinical trials using multiple doses of cefpodoxime proxetil film-coated tablets, 4696 patients were treated with the recommended dosages of cefpodoxime (100 to 400 mg Q 12 hours). There were no deaths or permanent disabilities thought related to drug toxicity. One-hundred twenty-nine (2.7%) patients discontinued medication due to adverse events thought possibly or probably related to drug toxicity. Ninety-three (52%) of the 178 patients who discontinued therapy (whether thought related to drug therapy or not) did so because of gastrointestinal disturbances, nausea, vomiting, or diarrhea.

Source: FDA prescribing information (DailyMed). Set ID: 59d848e9-de7a-669b-e063-6394a90a2b35. SPL document ID: 59d848be-c5aa-6781-e063-6394a90a741e. Label effective date: August 25, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Contraindications for Cefpodoxime (FDA label)

Cefpodoxime proxetil is contraindicated in patients with a known allergy to cefpodoxime or to the cephalosporin group of antibiotics.

Source: FDA prescribing information (DailyMed). Set ID: 59d848e9-de7a-669b-e063-6394a90a2b35. SPL document ID: 59d848be-c5aa-6781-e063-6394a90a741e. Label effective date: August 25, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.

Drug interactions for Cefpodoxime (FDA label)

Antacids: Concomitant administration of high doses of antacids (sodium bicarbonate and aluminum hydroxide) or H 2 blockers reduces peak plasma levels by 24% to 42% and the extent of absorption by 27% to 32%, respectively. The rate of absorption is not altered by these concomitant medications. Oral anti-cholinergics (e.g., propantheline) delay peak plasma levels (47% increase in T max ), but do not affect the extent of absorption (AUC). Probenecid: As with other beta-lactam antibiotics, renal excretion of cefpodoxime was inhibited by probenecid and resulted in an approximately 31% increase in AUC and 20% increase in peak cefpodoxime plasma levels. Nephrotoxic drugs: Although nephrotoxicity has not been noted when cefpodoxime proxetil was given alone, close monitoring of renal function is advised when cefpodoxime proxetil is administered concomitantly with compounds of known nephrotoxic potential.

Source: FDA prescribing information (DailyMed). Set ID: 59d848e9-de7a-669b-e063-6394a90a2b35. SPL document ID: 59d848be-c5aa-6781-e063-6394a90a741e. Label effective date: August 25, 2026. Read the full label.

Excerpt from the FDA-approved prescribing information. This is not medical advice; talk to your doctor or pharmacist.